Management of Elevated Total Globulin

Initial Diagnostic Workup

The American College of Physicians recommends ordering serum protein electrophoresis (SPEP) and immunofixation to detect monoclonal proteins, which indicate plasma cell dyscrasias requiring hematology referral 1
Quantitative immunoglobulins (IgG, IgA, IgM) should be measured to characterize the specific pattern of elevation, as recommended by the American Society of Clinical Oncology 1
Serum free light chain assay should be obtained to detect light chain production and calculate the kappa/lambda ratio, according to the International Myeloma Society 1
Complete blood count with differential should be performed to assess for cytopenias suggesting bone marrow involvement, as suggested by the National Comprehensive Cancer Network 1

The Mayo Clinic recommends referring immediately to hematology/oncology for evaluation of multiple myeloma, Waldenström macroglobulinemia, or other plasma cell dyscrasia 1
Bone marrow aspiration and biopsy with immunophenotyping should be performed to assess plasma cell percentage and clonality, as recommended by the European Society for Medical Oncology 1
Skeletal survey or MRI of spine and pelvis should be ordered to detect bone lesions, according to the American College of Radiology 1
Cytogenetic analysis and FISH studies on bone marrow samples should be obtained to assess for high-risk features, as suggested by the International Myeloma Society 1

The American Association for the Study of Liver Diseases recommends screening for chronic infections, including viral hepatitis (hepatitis B and C) and HIV, as these commonly cause polyclonal hyperglobulinemia 2
Evaluation for autoimmune conditions, particularly autoimmune hepatitis, should be performed, as recommended by the American College of Gastroenterology 2

Disease-specific treatment protocols for multiple myeloma or Waldenström macroglobulinemia should be followed, as determined by hematology/oncology, according to the National Comprehensive Cancer Network 1
Monitoring for hyperviscosity syndrome in patients with very high globulin levels, particularly IgM >30 g/L, is recommended by the American Society of Clinical Oncology 3
Funduscopic examination should be performed rather than relying solely on laboratory values, as hyperviscosity symptoms correlate poorly with measurements, as suggested by the American Academy of Ophthalmology 1

Total serum globulin or γ-globulin or IgG >1.5× ULN supports definite diagnosis of autoimmune hepatitis, while any elevation above ULN supports probable diagnosis, according to the American Association for the Study of Liver Diseases 2
Autoantibodies (ANA, SMA, anti-LKM-1) at titers ≥1:80 support definite diagnosis, as recommended by the European Association for the Study of the Liver 2
Serum aminotransferases and alkaline phosphatase ratio should be assessed, as AP:AST ratio <1.5 scores points toward autoimmune hepatitis, according to the American College of Gastroenterology 2

For monoclonal gammopathy requiring treatment, disease-specific protocols for monitoring response should be followed, as recommended by the National Comprehensive Cancer Network 1
For MGUS patients, surveillance should be continued according to risk stratification, as suggested by the International Myeloma Society 1
For polyclonal gammopathy, repeat protein electrophoresis after treating underlying condition should be performed to confirm resolution, according to the American College of Physicians 1

Bone‑marrow aspiration and biopsy with immunophenotyping are required to determine the proportion of clonal plasma cells; a threshold of ≥10 % clonal plasma cells establishes the diagnosis of multiple myeloma. This recommendation follows the International Myeloma Working Group consensus. 4
Skeletal survey or whole‑body MRI should be performed to identify lytic bone lesions, which are a defining feature of symptomatic myeloma and trigger the need for treatment. This imaging guidance is endorsed by the International Myeloma Working Group. 4
Diagnostic thresholds for plasma‑cell disorders:
- MGUS is defined by an M‑protein concentration <3 g/dL and <10 % plasma cells in the marrow, without end‑organ damage.
- Symptomatic multiple myeloma requires ≥10 % clonal plasma cells plus at least one CRAB feature (hypercalcemia, renal insufficiency, anemia, or bone lesions). These criteria are based on International Myeloma Working Group guidelines. 4

Comprehensive liver function testing (including ALT, AST, alkaline phosphatase, bilirubin, and PT/INR) is recommended to assess for chronic liver disease when a calculated globulin elevation is identified. This approach is supported by the British Society of Gastroenterology clinical guidance. 5